Damora Therapeutics grants options for 144,400 shares to new hires at $21.28 exercise price
Bitget2026/10/02 11:59- Damora Therapeutics granted inducement stock options covering 144,400 ordinary shares to five newly hired non-executive employees.
- Options carry a 10-year term with an exercise price of $21.28 per share.
- Vesting starts with 25% on the first anniversary of each employee’s start date, then monthly installments over 36 months.
- Awards were issued on Oct. 1, 2026 under the 2022 Inducement Plan.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pimco warns: 10-year US Treasury yield may hit 6%, for the first time since 2000
PIMCO's Chief Investment Officer stated that due to high oil prices intensifying inflation concerns and market unease over the growing U.S. public debt, the benchmark 10-year U.S. Treasury yield could rise to 6% for the first time since 2000.
Altcoin Rises 138% in One Month and Enters Top 20, What’s Behind the Rally? Here Are the Details
OpenAI's annualized revenue aims for $70 billions, with enterprise business as a driving force
According to sources familiar with the matter, OpenAI is expected to reach or exceed an annualized revenue of 7 billion dollars by the end of this year, mainly driven by the growth of its enterprise business.
Crypto prices
More
